| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |